ConductScience.org, home

Gene · 3313

NIH grants1,948

NIH grants whose papers are about the gene, through NIH's grant-paper links.

561 to 580 of 1,948

Download this page as JSON
GrantTitleHSPA9 papersNewest fiscal year
P20GM104357Cardiorenal and Metabolic Diseases Research Center12022
P30DK079307Pittsburgh Center for Kidney Research12022
P30DK079337UAB-UCSD O'Brien Center for Acute Kidney Injury Research12022
P30ES006096Center for Environmental Genetics12022
P50NS108675Innate and Adaptive Immunity in Parkinson Disease12022
R01AA026914Role of the heme-related mitochondrial antioxidant ABCB10 in alcoholic liver disease12022
R01AG019719Role of epigenetic decay in cell senescence and aging12022
R01AG055518Mitochondrial biogenesis, genetics and cell loss in mammalian aging12022
R01AG056944Bladder Mucosal Dysfunction During Aging12022
R01AG058812Role of CD38 in NAD metabolism: from the basic biology of aging to translation12022
R01AI134611Structural Basis for Antiviral Drug Mitochondrial Toxicity12022
R01AI135005Development of a multivalent vaccine against Coccidioides infection12022
R01AR042527Oligoclonal T Cell Expansion and Rheumatoid Arthritis12022
R01CA096500Role of KSHV Viral Proteins in Signaling and Pathogenesis12022
R01CA124723Role of HSP70 in Pancreatic Diseases12022
R01CA217642Molecular Mechanism and Therapy for Ocular Melanoma12022
R01CA219342ATR Isomerization in Cellular Responses to UV Damage of DNA12022
R01CA222251Identification of USP13 as a therapeutic target for ovarian cancer12022
R01CA222508Tissue Tension, RANK and Breast Cancer Risk12022
R01CA226851Exploiting myeloma proteome remodeling to extend proteasome inhibitor efficacy12022

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3313/grants?page=29